Programmed cell death-ligand 1 (PD-L1) + tumour cells and low-reacting programmed cell death 1 (PD1) + tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus + diffuse large B-cell lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34515880/
doi: 10.1007/s10238-021-00754-4. Online ahead of print. 1 Graduate School of Medical Sciences, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan. 2 Department of Pathology, Faculty of Medicine, Fukuoka University, 7-45-1...
Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and EBER status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34520566/
Elevated Epstein-Barr virus (EBV) DNA load is common in lymphomas. However, it remains unclear whether the disparity in viral load and its prognostic value in lymphomas are correlated with EBER...
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34515338/
The available evidence on the benefits and harms of CAR T-cell therapy for people with r/r DLBCL is limited, mainly because of the absence of comparative clinical trials. The results...
The microenvironment of DLBCL is characterized by non-canonical macrophages recruited by tumor-derived CCL5 - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34516642/
Tissue invasion by tumor cells induces a host inflammatory response variably impacting tumorigenesis. This has been well documented for tumor-associated macrophages (TAM) that could either play a pro/M2 or an...
Application of CD54 in diagnosing bone marrow involvement by using flow cytometry in patients with diffuse large B-cell lymphoma - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34503477/
Aberrant expression of CD54 on lymphoma cells is frequently seen in patients' BM specimens involved by DLBCL, especially in the non-GCB subtype. CD54 could be used as a new marker...
-
DLBCL Connect4yrKey Points • Conclusion/Relevance: “Aberrant expression of CD54 on lymphoma cells is frequently seen in patients’ BM specimens involved by DLBCL, especially in the non-GCB subtype. CD54 could be used as a Show More